Prof. Ruggero De Paulis

MVT Aortic 2022, vol.1

– First and foremost, not all bicuspid aortic valves are the same

– Many post-operative measurements and goals are included within to help guide you to optimal patient outcomes

– Check out the insight provided about valve-sparing, valve repair, external annuloplasty, and more

Prof. Alessandro Della Corte

MVT Aortic 2022, vol.1

– New classification system and nomenclature of bicuspid aortic valve (and bicuspid aortic valve disease)

– Genes are important, but a single gene may contribute to fewer than 1% of cases

– Different valve repair techniques according to valve phenotype

Prof. Marjan Jahangiri

MVT Aortic 2022, vol.1

– Shorter time to extubation, shorter length of stay, shorter hospital stays

– Pre-operative strategies to enhance post-operative and follow-up outcomes

– Don’t forget to pay attention to the intra-operative details and work with the entire Heart Team for optimal patient outcomes

Prof. Marco Di Eusanio

MVT Aortic 2022, vol.1

– Minimally invasive: much more than just a small cut

– Already achieved a low mortality rate? Set new goals for new targets related to patient quality of life.

– Always consider… Do you need to be cautious with the sternum? Is the patient obese? Are you an experienced surgeon? Don’t forget to perform an Angio CT scan.

Prof. Bart Meuris

MVT Aortic 2022, vol.1

-Cosmesis vs clinical benefit? Cross-clamp times? Extra costs? Have you thought about these aspects before?

-What about less pain? Less blood loss? Shorter ICU stays? Lower rates of atrial fibrillation? Remember, there are always pros and cons.

-If combined procedures are necessary, minimally invasive can be a choice in experienced centers

Prof. Marjan Jahangiri

MVT Aortic 2022, vol.1

– Pay attention to comorbidities, the anticoagulation choice may not as simple as it seems

– Be aware of the limitations of the currently available studies, question them in a logical manner

Prof. Joseph Bavaria

MVT Aortic 2022, vol.1

Prof. Michael Borger

MVT Aortic 2022, vol.1

-The “aortic size paradox”: an interesting paradox, indeed

-Length? Diameter? Which should we pay more attention to?

-Be sure to pay attention to genetics, biomarkers, abnormal flow, other risk factors, and more

Prof. Friedhelm Beyersdorf

MVT Aortic 2022, vol.1

– Guidelines: based on scientific data, not an individual hospital’s, country’s, or region’s practices.

– It’s important to truly understand the recommendations and evidence classifications.

–Pay attention to the details in phrasing.

Prof. Marco Di Eusanio

MVT Aortic 2022, vol.1

Prof. Augusto d’Onofrio

MVT Aortic 2022, vol.1

– Valve-in-valve, TAVI in TAVI, SAVR after TAVI… familiarize yourself with the mid-to-long-term data for each valve type combination, and transparently inform the patients of not only the benefits but also the risks

– Even the experts say, extracting an infected TAVI is extremely difficult, so be sure to choose the original valve wisely

Prof. Bart Meuris

MVT Aortic 2022, vol.1

• Shorter hospital stays, less anticoagulation, long-term financial savings? Hear about the data of an expert’s personal experience.

• With advanced anti-calcification treatment, the future of bioprostheses is promising not only for patient outcomes, but even from a financial perspective

Dr. Douglas Johnston

STS annual meeting 202

Dr. Holzhey – MVT Intermediate 2021